Abiopharma

🔍 Mair Scott (Director)

Company: Ribbon Communications Inc. (RBBN)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 67,500 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 208,138.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 63,197 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-06-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 63,197.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 67,500 shares of RSUs (Derivative)
  Date: 2026-06-16 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• F2: The RSUs will vest on June 15, 2027, subject to the Reporting Person's continued service with the Issuer through such date; provided, however, that if the Issuer's 2027 Annual Meeting of Stockholders (the "2027 Annual Meeting") occurs prior to June 15, 2027, and, at such 2027 Annual Meeting, the Reporting Person either chooses not to stand for re-election to the Issuer's Board of Directors or, after standing for re-election, is not re-elected, then these RSUs will vest as of the date of the 2027 Annual Meeting.
• F3: The RSUs were awarded on June 16, 2025 and vested in full on June 16, 2026.